Vaccinating sons against HPV: results from a U.S. national survey of parents.

Purpose: The quadrivalent HPV vaccination was approved for use in males ages 9 to 26 in 2009 and recommended for routine administration in 2011. The purpose of this study was to uncover predictable commonalities amongst parents who chose to vaccinate their 11-17 year old sons against HPV.

Methods: We compiled data from a U.